The effects of Staphylococcus aureus leukotoxins on the host: cell lysis and beyond
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
The success of Staphylococcus aureus as a leading cause of deadly hospital-acquired and community-acquired infections is attributed to its high-level resistance to most antibiotics, and the multitude of virulence factors it elaborates. Most clinical isolates produce up to four bi-component pore-forming toxins capable of lysing cells of the immune system. Subtle differences in activity and target range of each leukotoxin suggest that these toxins are not redundant, but instead may have specialized functions in attacking and/or evading host defenses. In turn, the host has developed countermeasures recognizing sublytic levels of leukotoxins as signals to activate protective immune defenses. The opposing cytotoxic and immune-activating effects of leukotoxins on host cells make for a complex dynamic between S. aureus and the host.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lina, G., Piemont, Y., Godail-Gamot, F., Bes, M., Peter, M.-O., Gauduchon, V., Vandenesch, F., & Etienne, J. (1999) · Clinical Infectious Diseases · doi:10.1086/313461 · Cited by 2,489 · cited 1×
“aureus clinical strains, although it is strongly associated with community-acquired MRSA strains ( 85%), in particular those causing pneumonia, and skin and soft tissue infections [2,26].”
BackgroundNaimi, T. S. (2003) · JAMA · doi:10.1001/jama.290.22.2976 · Cited by 1,688
Methicillin-Resistant Staphylococcus aureus Disease in Three Communities
Fridkin, S. K., Hageman, J. C., Morrison, M., Sanza, L. T., Como-Sabetti, K., Jernigan, J. A., Harriman, K., Harrison, L. H., Lynfield, R., & Farley, M. M. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043252 · Cited by 1,493
Basis of Virulence in Community-Associated Methicillin-Resistant Staphylococcus aureus
Otto, M. (2010) · Annual Review of Microbiology · doi:10.1146/annurev.micro.112408.134309 · Cited by 457 · cited 1×
“aureus as a pathogen can be attributed to its arsenal of virulence factors designed to evade or attack host defenses at every level [4,5].”
BackgroundDiep, B. A., Chan, L., Tattevin, P., Kajikawa, O., Martin, T. R., Basuino, L., Mai, T. T., Marbach, H., Braughton, K. R., Whitney, A. R., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912403107 · Cited by 347 · cited 2×
“One study showed that PVL conferred a modest transient advantage to Current Opinion in Microbiology 2013, 16:63–69 S. aureus in the early stages of bacteremia and in a pneumonia model, but only at very high inocula (>5 109 CFU) [33,34].”
BackgroundGravet, A., Colin, D. A., Keller, D., Giradot, R., Monteil, H., & Prévost, G. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01130-2 · Cited by 177 · cited 1×
“LukED Despite the initial report of this toxin over a decade ago [14,18], research on LukED has remained minimal.”
BackgroundLi, M., Cheung, G. Y. C., Hu, J., Wang, D., Joo, H., DeLeo, F. R., & Otto, M. (2010) · The Journal of Infectious Diseases · doi:10.1086/657419 · Cited by 175 · cited 1×
“aureus is grown under different conditions [47,48].”
Alonzo III, F., Benson, M. A., Chen, J., Novick, R. P., Shopsin, B., & Torres, V. J. (2012) · Molecular Microbiology · doi:10.1111/j.1365-2958.2011.07942.x · Cited by 155 · cited 2×
“As mentioned in the preceding section, in addition to its toxicity toward human neutrophils and rabbit red blood cells, LukED is unique in being highly effective at killing mouse phagocytes [20].”
BackgroundSelf-citationLipinska, U., Hermans, K., Meulemans, L., Dumitrescu, O., Badiou, C., Duchateau, L., Haesebrouck, F., Etienne, J., & Lina, G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022864 · Cited by 100 · cited 1×
“showed the PVL strain to cause more significant skin necrosis compared to the isogenic Dpvl strain [35].”
Cited by
Staphylococcus aureus Toxins and Their Molecular Activity in Infectious Diseases
Oliveira, D., Borges, A., & Simões, M. (2018) · Toxins · doi:10.3390/toxins10060252 · Cited by 485
Staphylococcus aureus Secreted Toxins and Extracellular Enzymes
Tam, K., & Torres, V. J. (2019) · Microbiology Spectrum · doi:10.1128/microbiolspec.gpp3-0039-2018 · Cited by 452
Self-citationKalan, L. R., Meisel, J. S., Loesche, M. A., Horwinski, J., Soaita, I., Chen, X., Uberoi, A., Gardner, S. E., & Grice, E. A. (2019) · Cell Host & Microbe · doi:10.1016/j.chom.2019.03.006 · Cited by 397
Leukocidins: staphylococcal bi-component pore-forming toxins find their receptors
Spaan, A. N., van Strijp, J. A. G., & Torres, V. J. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.27 · Cited by 347
Self-citationThe Bicomponent Pore-Forming Leucocidins of Staphylococcus aureus
Alonzo, F., & Torres, V. J. (2014) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00055-13 · Cited by 276
Self-citation
Metadata
- Authors
- Yoong, P., & Torres, V. J.
- Venue
- Current Opinion in Microbiology
- Publisher
- Elsevier BV
- Published
- 2013-02
- Volume
- 16
- Issue
- 1
- Pages
- 63-69
- ISSN
- 1369-5274 (ISSN-L)
- OpenAlex
- W2059349393
- Cited by
- 123
- References
- 9
- FWCI
- 1.38
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.